These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17616688)
1. Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy. Ohtani S; Iwamaru A; Deng W; Ueda K; Wu G; Jayachandran G; Kondo S; Atkinson EN; Minna JD; Roth JA; Ji L Cancer Res; 2007 Jul; 67(13):6293-303. PubMed ID: 17616688 [TBL] [Abstract][Full Text] [Related]
2. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Ji L; Nishizaki M; Gao B; Burbee D; Kondo M; Kamibayashi C; Xu K; Yen N; Atkinson EN; Fang B; Lerman MI; Roth JA; Minna JD Cancer Res; 2002 May; 62(9):2715-20. PubMed ID: 11980673 [TBL] [Abstract][Full Text] [Related]
3. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1. Deng WG; Wu G; Ueda K; Xu K; Roth JA; Ji L Cancer Gene Ther; 2008 Jan; 15(1):29-39. PubMed ID: 17828283 [TBL] [Abstract][Full Text] [Related]
5. Electron transfer reactions of candidate tumor suppressor 101F6 protein, a cytochrome b561 homologue, with ascorbate and monodehydroascorbate radical. Recuenco MC; Rahman MM; Takeuchi F; Kobayashi K; Tsubaki M Biochemistry; 2013 May; 52(21):3660-8. PubMed ID: 23641721 [TBL] [Abstract][Full Text] [Related]
6. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Ueda K; Kawashima H; Ohtani S; Deng WG; Ravoori M; Bankson J; Gao B; Girard L; Minna JD; Roth JA; Kundra V; Ji L Cancer Res; 2006 Oct; 66(19):9682-90. PubMed ID: 17018626 [TBL] [Abstract][Full Text] [Related]
7. Functional expression and characterization of human 101F6 protein, a homologue of cytochrome b561 and a candidate tumor suppressor gene product. Recuenco MC; Fujito M; Rahman MM; Sakamoto Y; Takeuchi F; Tsubaki M Biofactors; 2008; 34(3):219-30. PubMed ID: 19734123 [TBL] [Abstract][Full Text] [Related]
8. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
9. Involvement of 101F6, a homologue of cytochrome b561, in the reduction of ferric ions. Mizutani A; Sanuki R; Kakimoto K; Kojo S; Taketani S J Biochem; 2007 Dec; 142(6):699-705. PubMed ID: 17938141 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the recombinant human tumour suppressor 101F6 protein, a cytochrome b(561) homologue. Recuenco MC; Rahman MM; Sakamoto Y; Takeuchi F; Hori H; Tsubaki M J Biochem; 2013 Feb; 153(2):233-42. PubMed ID: 23235316 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126 [TBL] [Abstract][Full Text] [Related]
12. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163 [TBL] [Abstract][Full Text] [Related]
13. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Oh JJ; West AR; Fishbein MC; Slamon DJ Cancer Res; 2002 Jun; 62(11):3207-13. PubMed ID: 12036935 [TBL] [Abstract][Full Text] [Related]
14. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy. Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759 [TBL] [Abstract][Full Text] [Related]
15. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1. Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223 [TBL] [Abstract][Full Text] [Related]
16. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related]
17. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Zhu K; Fang W; Chen Y; Lin S; Chen X Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1. Lin J; Sun T; Ji L; Deng W; Roth J; Minna J; Arlinghaus R Oncogene; 2007 Oct; 26(49):6989-96. PubMed ID: 17486070 [TBL] [Abstract][Full Text] [Related]
19. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer. Lu L; Zhang X; Zhang B; Wu J; Zhang X Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008 [TBL] [Abstract][Full Text] [Related]
20. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Ito I; Ji L; Tanaka F; Saito Y; Gopalan B; Branch CD; Xu K; Atkinson EN; Bekele BN; Stephens LC; Minna JD; Roth JA; Ramesh R Cancer Gene Ther; 2004 Nov; 11(11):733-9. PubMed ID: 15486560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]